戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 they documented 138 newly diagnosed cases of duodenal ulcer.
2 toris, bronchial asthma, herpes simplex, and duodenal ulcer.
3 al with severe abdominal pain and a ruptured duodenal ulcer.
4 ors in the development of gastric cancer and duodenal ulcer.
5 ting the risk of gastric cancer from that of duodenal ulcer.
6 gastric ulcer and 2.6 (95% CI: 1.1, 5.8) for duodenal ulcer.
7 astric ulcer and 5.8 (95% CI: 1.1, 30.0) for duodenal ulcer.
8 gastric ulcer and 2.5 (95% CI: 0.8, 7.4) for duodenal ulcer.
9 f H. pylori in infected patients with active duodenal ulcers.
10 gastritis and the development of stomach and duodenal ulcers.
11 cag(-) H. pylori strain for both gastric and duodenal ulcers.
12 antly associated with gastritis, gastric and duodenal ulcers.
13  are paradoxically protected from developing duodenal ulcers.
14 ith diarrhea, heartburn, abdominal pain, and duodenal ulcers.
15 ative role in the development of gastric and duodenal ulcers.
16  associated with absence of gastric ulcer or duodenal ulcer (0.21 [0.05 to 0.94] and 0.31 [0.12 to 0.
17 ing present in 60%-80% of gastric and 95% of duodenal ulcers.(1)H pylori is also the first bacterium
18 ts), gastric ulcer (14), gastritis (12), and duodenal ulcer (10).
19 cured patients (6% vs. 67% for patients with duodenal ulcers; 4% vs. 59% for patients with gastric ul
20 ees for all procedures (surgery for bleeding duodenal ulcer, 42% versus 26%, adjusted odds ratio (AOR
21 71]) associated with gastric ulcer than with duodenal ulcer (86 versus 56%).
22 in 2006 (-29.9%), with a larger reduction in duodenal ulcers (95,552 in 1993 vs. 60,029 in 2006, -37.
23 r that could distinguish gastric cancer from duodenal ulcer (adjusted odds ratio, 3.033; 95% confiden
24 -twenty patients; 116 with gastritis, 3 with duodenal ulcer and 1 gastric ulcer, were studied.
25 of Helicobacter pylori as the major cause of duodenal ulcer and development of effective eradication
26 fectiveness studies of various approaches to duodenal ulcer and dyspeptic patients.
27                                     Fourteen duodenal ulcer and five gastric ulcer studies satisfied
28  causative agent of stomach diseases such as duodenal ulcer and gastric cancer, in this regard incomp
29  as well as two mutually exclusive diseases, duodenal ulcer and gastric carcinoma.
30           There were two grade 4 toxicities: duodenal ulcer and hyponatremia.
31  One (1%) patient developed an acute grade 4 duodenal ulcer and late grade 4 gastritis.
32 s compared with that of age- and sex-matched duodenal ulcer and nonulcer dyspepsia patients (16 each)
33        The association between acute gastric/duodenal ulcer and opium use has been previously propose
34 n H. pylori may lead to the disappearance of duodenal ulcers and distal gastric cancers and toward a
35  subset of individuals to develop gastric or duodenal ulcers and even gastric cancer.
36 or contributing factor in the development of duodenal ulcers and is believed to be a significant risk
37 s showed numerous small (<10 mm) gastric and duodenal ulcers and multiple 10-15-mm polypoid gastric m
38 opsy samples was comparable in patients with duodenal ulcers and normal subjects without apparent rel
39            In patients with inactive, healed duodenal ulcers and normal subjects, the effect of H. py
40 and of age) were determined in patients with duodenal ulcers and normal subjects.
41 does not appear to be an association between duodenal ulcers and pancreatic cancer.
42 d gastrointestinal syndrome characterized by duodenal ulcers and strictures was observed in a subset
43  of the birth-cohort patterns of gastric and duodenal ulcers and their identical appearance in countr
44 total of 150 men with gastric ulcer, 65 with duodenal ulcer, and 14 with both diseases were identifie
45 le gastritis, 40 with gastric ulcer, 35 with duodenal ulcer, and 30 with gastric cancer.
46 ian populations (126 with gastritis, 96 with duodenal ulcer, and 64 with gastric cancer) by PCR.
47  13 for H. heilmannii (three gastritis, five duodenal ulcer, and five gastric ulcer samples), and 7 f
48 for H. bizzozeronii (zero gastric ulcer, two duodenal ulcer, and five gastritis samples).
49 significantly associated with gastric ulcer, duodenal ulcer, and gastric cancer (odds ratios [95% con
50 tory protein A may have predictive value for duodenal ulcer, and host alleles for interleukin-1beta,
51 ut significance) in mucus from patients with duodenal ulcer, and increased five times (with high sign
52 ples), 10 for H. felis (one gastritis, three duodenal ulcer, and six gastric ulcer samples), 20 for H
53 s for sustaining an NSAID-induced gastric or duodenal ulcer, and there has been progress in further u
54 onia, congestive heart failure, dehydration, duodenal ulcer, and urinary tract infection, were signif
55 ad gastritis, 92 had gastric ulcers, 108 had duodenal ulcers, and 65 had gastric cancer.
56 s effective in the prevention of gastric and duodenal ulcers, and erosive oesophagitis in patients ta
57 three patients had tumor-associated bleeding duodenal ulcers, and one had a contained duodenal perfor
58 t of diseases such as gastritis, gastric and duodenal ulcers, and two types of gastric cancers.
59 gastric pathogen associated with gastric and duodenal ulcers as well as specific gastric cancers.
60 ion, the best markers of gastric cancer- and duodenal ulcer-associated strains are the vacA s1 and i1
61  pneumatosis after endoscopic hemostasis for duodenal ulcer bleeding.
62                                He also had a duodenal ulcer, blood in the gastric lumen and a large p
63 ases gastric acid secretion in patients with duodenal ulcers but diminishes acid output in patients w
64 r were also inversely related to the risk of duodenal ulcer, but vitamin A from all sources combined
65 me trends of gastric ulcer preceded those of duodenal ulcer by 10-30 years.
66 s gastritis and atrophy, may protect against duodenal ulcers by decreasing acid output.
67                             Whereas incident duodenal ulcer cases represented only 2.4 percent of all
68 nts undergoing surgery (surgery for bleeding duodenal ulcer, cholecystectomy, appendectomy, and colec
69 aired bicarbonate secretion in patients with duodenal ulcers could be caused by a cellular and/or phy
70 al relationship between the dupA cluster and duodenal ulcer development is not proved, the presence o
71 n of Helicobacter pylori, is associated with duodenal ulcer development.
72 uster but not dupA alone, is associated with duodenal ulcer development.
73 ori, who are known to have increased risk of duodenal ulcer disease and gastric cancer.
74                                Patients with duodenal ulcer disease have impaired proximal duodenal m
75 e agent of chronic superficial gastritis and duodenal ulcer disease in humans, produces a unique cyto
76 e consistent with H. pylori infection (e.g., duodenal ulcer disease), rapid urease testing and DNA se
77 m of dogs, Trichuris vulpis, in a woman with duodenal ulcer disease, chronic diarrhea, and close cont
78 hough Helicobacter pylori is associated with duodenal ulcer disease, most patients infected with the
79 inical outcomes including gastric cancer and duodenal ulcer disease.
80 ex matched to 4 controls and with a parallel duodenal ulcer (DU) group.
81 rica, including 120 with gastritis, 140 with duodenal ulcer (DU), 110 with gastric ulcer (GU), and 13
82 dy, Vietnamese patient H. pylori samples (46 duodenal ulcer (DU), 51 non-cardia gastric cancer (NCGC)
83 cers (GU) were diagnosed in 2095 (8%) cases, duodenal ulcers (DU) in 2276 (9%) cases and 239 (1%) had
84 y mimic acute diverticulitis, cholecystitis, duodenal ulcer, duodenitis, enteritis, or adnexal or tes
85                             In patients with duodenal ulcers, eradication of H. pylori normalized pro
86 s of gastric ulcer rose by 22 %, and that of duodenal ulcer fell by 14 % per decade.
87 ic ulcer samples), 20 for H. salomonis (four duodenal ulcer, five gastritis, and 11 gastric ulcer sam
88 n logistic regression models to discriminate duodenal ulcer from gastritis.
89  The age-specific death rates of gastric and duodenal ulcers from each individual country were plotte
90 whelm mucosal defense mechanisms, leading to duodenal ulcer, gastric ulcer, and gastroesophageal refl
91 erall burden of PUD in Africa, its patterns (duodenal ulcers, gastric ulcers, and coexisting ulcers),
92                                  Gastric and duodenal ulcers (GDUs) are decreasing both in frequency
93                             In patients with duodenal ulcers, H. pylori eradication normalized proxim
94 atio [OR] 0.20, 95% CI 0.09-0.47; p=0.0002); duodenal ulcers had developed in one (0.5%) patient comp
95                           Most patients with duodenal ulcers have impaired proximal duodenal mucosal
96 Eradication of Helicobacter pylori expedites duodenal ulcer healing and prevents recurrences.
97 sociations have been previously reported for duodenal ulcer, here replicated trans-ancestrally.
98 en used to perform vagotomy in patients with duodenal ulcer; however, no direct comparisons are avail
99 . pylori eradication exclusively in inactive duodenal ulcer (iDU) or non-ulcer dyspepsia (NUD).
100 atic cancer and the occurrence of gastric or duodenal ulcer in a large US cohort.
101 ions between dietary factors and the risk of duodenal ulcer in a prospective cohort of 47,806 men, ag
102 es alike, the risk of dying from gastric and duodenal ulcer increased among consecutive generations b
103                             In patients with duodenal ulcer, infection with Helicobacter pylori is as
104 to become accepted therapy for patients with duodenal ulcer managed presently with OPGV.
105 and stimulated acid outputs in patients with duodenal ulcer, most people infected with the organism a
106 d including gastroduodenitis (n=10), gastric/duodenal ulcer (n=2), and hemorrhagic esophagitis (n=1).
107            In 1 patient, a treatment-related duodenal ulcer occurred.
108 years, who were free of diagnosed gastric or duodenal ulcer or cancer.
109 ntly higher incidence of personal history of duodenal ulcer (P = .02).
110 versus 78% of 18 isolates from patients with duodenal ulcers (P = 0.344) and only 64% of 22 isolates
111  43%, respectively, for surgery for bleeding duodenal ulcer, P < 0.0001 for all comparisons).
112 om a non-cardia gastric cancer patient and a duodenal ulcer patient, respectively, and their virulenc
113 c-cancer patients (71.9%) than in those from duodenal ulcer patients (52.1%) (P = 0.012).
114 ntral bacteria] density was 5-fold higher in duodenal ulcer patients than in others (P = .005).
115 nd vegetables, may reduce the development of duodenal ulcer, possibly due to their fiber content.
116                                          The duodenal ulcer promoting (dupA) gene, located in the pla
117 passed both jhp0917 and jhp0918 called dupA (duodenal ulcer promoting gene) was associated with a spe
118 the outer membrane inflammatory protein; the duodenal ulcer-promoting gene, and possibly the blood gr
119 y efficacy end point for reduced gastric and duodenal ulcer recurrence for the purpose of clinical tr
120                For H. pylori-cured patients, duodenal ulcer recurrence was higher in studies using tw
121  12 months) was not significantly related to duodenal ulcer recurrence.
122 vegetables was associated with lower risk of duodenal ulcer (relative risk (RR) = 0.67, 95% confidenc
123 resence of a complete dupA cluster increases duodenal ulcer risk compared to H. pylori infection with
124 strongly associated with a decreased risk of duodenal ulcer (RR = 0.40, 95% CI 0.22-0.74 for the high
125 ke was inversely associated with the risk of duodenal ulcer (RR = 0.55, 95% CI 0.31-0.96 for men in t
126 ion, and apoptosis in gerbil mucosa than did duodenal ulcer strain G1.1, and gastric ulceration and a
127 ome of 21 captive marmosets diagnosed with a duodenal ulcer/stricture (57 samples).
128 cephalic-vagal stimulation) in patients with duodenal ulcers, suggesting a generalized secretory defe
129 l inflammation and stricture, gastric ulcer, duodenal ulcer, suspected Barrett's esophagus (> or =2 c
130 ious clinical manifestations associated with duodenal ulcer than from patients with gastritis alone o
131 2.4 percent of all persons with a history of duodenal ulcer, the corresponding value for gastric ulce
132 y of NHPGH species was 10 for H. suis (three duodenal ulcer, three gastritis, and four gastric ulcer
133 rk-up revealed many clean-based non-bleeding duodenal ulcers to the third portion of the duodenum and
134                                 In contrast, duodenal ulcer was not associated with pancreatic cancer
135     Observed in 88 (30.6%) of UGIB patients, duodenal ulcer was the most common cause, followed by va
136                Altered DMBS in patients with duodenal ulcers was unrelated to histopathologic abnorma
137           Eradication rates in patients with duodenal ulcer were 82% (n = 51; 95% CI, 70-92) and 77%
138 ared with none in the risedronate group, and duodenal ulcers were noted in 1 evaluable subject in the
139          Three patients developed gastric or duodenal ulcers with severe bleeding requiring transfusi
140 d the risk for developing gastric cancer and duodenal ulcer, with the presence of the homB gene actin
141 lammatory drugs, and a history of gastric or duodenal ulcer, women with RA and no history of cardiac

 
Page Top